Literature DB >> 12007145

Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors.

Dmitri A A Vandeputte1, Dirk Troost, Sieger Leenstra, Helen Ijlst-Keizers, Marja Ramkema, D Andries Bosch, Frank Baas, Nab K Das, Eleonora Aronica.   

Abstract

The Id family of helix-loop-helix proteins is involved in a variety of processes, such as development, proliferation, and angiogenesis. In this study, we investigated the expression pattern of Id1, Id2, and Id3 in surgical specimens of human glial tumors. Western blot analysis demonstrated that all three Id proteins were expressed in astrocytic tumors. Expression levels in high-grade tumors were higher than in low-grade tumors. Immunohistochemical analysis confirmed that many of the tumor astrocytes exhibited strong Id1-3 IR. In contrast, in adult human normal brain, Id expression was low both in resting astrocytes and in endothelial cells. In tumor cells, Id proteins displayed cytoplasmic as well as nuclear localization. Id1-3 IR scores in tumor cells were positively correlated with proliferation indices. Moreover, Id1-3 IR was detected in endothelial cells of the astrocytic tumor blood vessels. The vascular Id1-3 expression correlated positively with tumor vascularity and grade. These results support the role of the Id gene family in the enhanced proliferative potential of tumor astrocytes. The evidence also supports the involvement of the Id gene family in tumor angiogenesis, a process that critically influences the malignant behavior of glial tumors. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007145     DOI: 10.1002/glia.10076

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  38 in total

1.  Phosphorylation Regulates Id2 Degradation and Mediates the Proliferation of Neural Precursor Cells.

Authors:  Jaclyn M Sullivan; Matthew C Havrda; Arminja N Kettenbach; Brenton R Paolella; Zhonghua Zhang; Scott A Gerber; Mark A Israel
Journal:  Stem Cells       Date:  2016-02-01       Impact factor: 6.277

2.  Identification of Id1 as a downstream effector for arsenic-promoted angiogenesis via PI3K/Akt, NF-κB and NOS signaling.

Authors:  Chun-Hao Tsai; Ming-Hui Yang; Amos C Hung; Shou-Cheng Wu; Wen-Chin Chiu; Ming-Feng Hou; Yu-Chang Tyan; Yun-Ming Wang; Shyng-Shiou F Yuan
Journal:  Toxicol Res (Camb)       Date:  2015-10-05       Impact factor: 3.524

3.  Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F.

Authors:  Silvia Coma; Dhara N Amin; Akio Shimizu; Anna Lasorella; Antonio Iavarone; Michael Klagsbrun
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

4.  Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice.

Authors:  Anna Lasorella; Gerson Rothschild; Yoshifumi Yokota; Robert G Russell; Antonio Iavarone
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 5.  What is the clinical value of cancer stem cell markers in gliomas?

Authors:  Rikke Hedegaard Dahlrot; Simon Kjær Hermansen; Steinbjørn Hansen; Bjarne Winther Kristensen
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

6.  Gene expression in oligodendroglial tumors.

Authors:  Elisabeth J Shaw; Brian Haylock; David Husband; Daniel du Plessis; D Ross Sibson; Peter C Warnke; Carol Walker
Journal:  Cell Oncol (Dordr)       Date:  2011-05-31       Impact factor: 6.730

7.  Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms.

Authors:  Anne-Laure Trépant; Christelle Bouchart; Sandrine Rorive; Sébastien Sauvage; Christine Decaestecker; Pieter Demetter; Isabelle Salmon
Journal:  Tumour Biol       Date:  2014-11-12

8.  Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target.

Authors:  Liliana Soroceanu; Ryuichi Murase; Chandani Limbad; Eric Singer; Juanita Allison; Isabel Adrados; Rumi Kawamura; Arash Pakdel; Yayoi Fukuyo; Daniel Nguyen; Sabeena Khan; Robert Arauz; Garret L Yount; Dan H Moore; Pierre-Yves Desprez; Sean D McAllister
Journal:  Cancer Res       Date:  2012-12-13       Impact factor: 12.701

9.  Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis.

Authors:  Francesco Niola; Xudong Zhao; Devendra Singh; Ryan Sullivan; Angelica Castano; Antonio Verrico; Pietro Zoppoli; Dinorah Friedmann-Morvinski; Erik Sulman; Lindy Barrett; Yuan Zhuang; Inder Verma; Robert Benezra; Ken Aldape; Antonio Iavarone; Anna Lasorella
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

10.  N-(4-Hydroxyphenyl) retinamide potentiated paclitaxel for cell cycle arrest and apoptosis in glioblastoma C6 and RG2 cells.

Authors:  Rajiv Janardhanan; Jonathan T Butler; Naren L Banik; Swapan K Ray
Journal:  Brain Res       Date:  2009-03-10       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.